Zhejiang Jiuzhou Pharmaceutical Co., Ltd (SHA:603456)

SHA:603456 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	2,667	3,206	1,095	1,121	324.57	565.15
Trading Asset Securities	-	-	-	26.06	27.45	-
Cash & Short-Term Investments	2,667	3,206	1,095	1,147	352.03	565.15
Cash Growth	-31.95%	192.71%	-4.49%	225.79%	-37.71%	84.62%
Accounts Receivable	1,310	997.69	767.03	850.02	691.24	563.81
Other Receivables	19.91	8.32	6.46	5.72	8.52	10.46
Receivables	1,330	1,006	773.49	855.74	699.77	574.27
Inventory	1,965	1,959	2,021	1,682	1,170	827.89
Other Current Assets	184.89	142.55	102.87	87.38	73.69	51.03
Total Current Assets	6,146	6,314	3,993	3,772	2,295	2,018
Property, Plant & Equipment	4,069	3,722	3,144	2,645	2,321	2,238
Long-Term Investments	112.12	121.88	109.13	101.07	29.87	19.9
Goodwill	109.39	110.11	111.11	70.35	75.07	75.07
Other Intangible Assets	507.17	504.74	454.03	412.47	235.78	276.46
Long-Term Deferred Tax Assets	0.17	0.75	24.43	11.21	7.58	7.46
Long-Term Deferred Charges	61.27	73.2	69.07	16.21	0.14	0.47
Other Long-Term Assets	2.99	4.74	8.38	12.15	36.54	35.03
Total Assets	11,009	10,852	7,914	7,040	5,002	4,670
Accounts Payable	1,222	1,198	1,245	988.14	530.25	349.32
Accrued Expenses	141.45	227.81	201.85	168.05	149.82	94.46
Short-Term Debt	-	-	50.05	498.84	788.02	341.09
Current Portion of Long-Term Debt	116.33	7.77	200.21	-	10.01	40.06
Current Portion of Leases	-	6.78	6.59	1.01	-	-
Current Income Taxes Payable	54.7	55.3	78.8	75.37	26.86	16.22
Current Unearned Revenue	91.86	75.41	83.08	49.64	22.76	20.06
Other Current Liabilities	58.91	85.95	348.37	303.65	105.32	330.81
Total Current Liabilities	1,685	1,657	2,214	2,085	1,633	1,192
Long-Term Debt	375.95	389.05	83.99	201.49	140.19	490.7
Long-Term Leases	8.74	11.89	10.6	3.25	-	-
Long-Term Unearned Revenue	121.71	109.12	101.2	97.31	92.49	105.29
Long-Term Deferred Tax Liabilities	118.63	101.47	106.26	76.55	49.95	23.91
Other Long-Term Liabilities	75.13	50.77	25.76	-	-	-
Total Liabilities	2,386	2,319	2,542	2,463	1,916	1,812
Common Stock	899.44	899.49	834.25	832.6	805.23	805.66
Additional Paid-In Capital	4,505	4,499	2,058	1,985	971.34	940.23
Retained Earnings	3,375	3,190	2,515	1,802	1,335	1,115
Treasury Stock	-230.71	-132.01	-113.12	-44.43	-30.66	-9.39
Comprehensive Income & Other	0.76	4.65	2.26	1.49	2.54	3.3
Total Common Equity	8,549	8,461	5,297	4,577	3,083	2,855
Minority Interest	73.91	71.94	75.1	-	2.91	3.73
Shareholders' Equity	8,623	8,533	5,372	4,577	3,086	2,858
Total Liabilities & Equity	11,009	10,852	7,914	7,040	5,002	4,670
Total Debt	501.02	415.49	351.44	704.58	938.22	871.84
Net Cash (Debt)	2,166	2,791	743.98	442.29	-586.2	-306.69
Net Cash Growth	-25.69%	275.13%	68.21%	-	-	-
Net Cash Per Share	2.40	3.13	0.90	0.53	-0.72	-0.39
Filing Date Shares Outstanding	899.44	899.49	834.25	832.6	831.41	805.66
Total Common Shares Outstanding	899.44	899.49	834.25	832.6	805.23	805.66
Working Capital	4,461	4,658	1,779	1,687	662.34	826.32
Book Value Per Share	9.51	9.41	6.35	5.50	3.83	3.54
Tangible Book Value	7,933	7,846	4,732	4,094	2,772	2,503
Tangible Book Value Per Share	8.82	8.72	5.67	4.92	3.44	3.11
Buildings	-	1,786	1,612	1,562	1,354	1,299
Machinery	-	4,350	4,010	3,684	3,326	3,133
Construction In Progress	-	1,198	839.25	471.51	300.08	273.78

Updated Oct 24, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.